The effects of graded doses of endothelin-1 on coronary perfusion pressure and vital organ blood flow during cardiac arrest

Daniel Debehnke

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Endothelin-1 (ET-1) is a potent vasoconstrictor and has been shown to improve coronary perfusion pressure (CPP) during arrest. The effects of ET-1 on organ blood flow during arrest have not been extensively studied. Objective: To investigate the effects of ET-1 on myocardial and cerebral blood flow during cardiac arrest. Methods: Sixty immature swine were anesthetized and instrumented. The animals were randomized to receive one of three doses of ET-1 (50, 150, or 300 μg) or placebo with/without standard- dose epinephrine (SDE) during cardiac arrest. After a 10-minute period of no- flow ventricular fibrillation (VF), cardiopulmonary resuscitation (CPR) was performed for 3 minutes, followed by drug administration. Placebo or SDE was given every 3 minutes. Myocardial and cerebral blood flow was measured using a fluorescent microsphere technique. Results: Prearrest and CPR variables were not different between groups. Beginning 4 minutes after giving 300 μg ET-1 with or without SDE, CPP was significantly increased compared with SDE alone. Total myocardial blood flow following ET-1 administration was no different than myocardial blood flow following SDE alone. Cerebral blood flow increased 3.5 minutes after administration of 300 μg ET-1 with SDE and reached significance 9.5 minutes after drug administration when compared with SDE alone [92.5 (48.8-117.9) vs 15.6 (7.7-23) mL/min/100 g]. Conclusions: Three hundred μg ET-1 with SDE increases CPP and improves cerebral blood flow but does not improve myocardial blood flow during cardiac arrest. The peripheral effects of ET-1 significantly improve CPP and cerebral blood flow, but myocardial blood flow is not increased due to coronary vasoconstriction.

Original languageEnglish (US)
Pages (from-to)211-221
Number of pages11
JournalAcademic Emergency Medicine
Volume7
Issue number3
DOIs
StatePublished - Mar 2000

Fingerprint

Endothelin-1
Heart Arrest
Cerebrovascular Circulation
Epinephrine
Perfusion
Pressure
Cardiopulmonary Resuscitation
Placebos
Vasoconstrictor Agents
Ventricular Fibrillation
Vasoconstriction
Microspheres
Pharmaceutical Preparations
Swine

Keywords

  • Blood flow
  • Cardiac arrest
  • Cardiopulmonary resuscitation
  • Coronary perfusion pressure
  • Endothelin

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

The effects of graded doses of endothelin-1 on coronary perfusion pressure and vital organ blood flow during cardiac arrest. / Debehnke, Daniel.

In: Academic Emergency Medicine, Vol. 7, No. 3, 03.2000, p. 211-221.

Research output: Contribution to journalArticle

@article{d12629ef84ec4aeea77f703979eb2824,
title = "The effects of graded doses of endothelin-1 on coronary perfusion pressure and vital organ blood flow during cardiac arrest",
abstract = "Background: Endothelin-1 (ET-1) is a potent vasoconstrictor and has been shown to improve coronary perfusion pressure (CPP) during arrest. The effects of ET-1 on organ blood flow during arrest have not been extensively studied. Objective: To investigate the effects of ET-1 on myocardial and cerebral blood flow during cardiac arrest. Methods: Sixty immature swine were anesthetized and instrumented. The animals were randomized to receive one of three doses of ET-1 (50, 150, or 300 μg) or placebo with/without standard- dose epinephrine (SDE) during cardiac arrest. After a 10-minute period of no- flow ventricular fibrillation (VF), cardiopulmonary resuscitation (CPR) was performed for 3 minutes, followed by drug administration. Placebo or SDE was given every 3 minutes. Myocardial and cerebral blood flow was measured using a fluorescent microsphere technique. Results: Prearrest and CPR variables were not different between groups. Beginning 4 minutes after giving 300 μg ET-1 with or without SDE, CPP was significantly increased compared with SDE alone. Total myocardial blood flow following ET-1 administration was no different than myocardial blood flow following SDE alone. Cerebral blood flow increased 3.5 minutes after administration of 300 μg ET-1 with SDE and reached significance 9.5 minutes after drug administration when compared with SDE alone [92.5 (48.8-117.9) vs 15.6 (7.7-23) mL/min/100 g]. Conclusions: Three hundred μg ET-1 with SDE increases CPP and improves cerebral blood flow but does not improve myocardial blood flow during cardiac arrest. The peripheral effects of ET-1 significantly improve CPP and cerebral blood flow, but myocardial blood flow is not increased due to coronary vasoconstriction.",
keywords = "Blood flow, Cardiac arrest, Cardiopulmonary resuscitation, Coronary perfusion pressure, Endothelin",
author = "Daniel Debehnke",
year = "2000",
month = "3",
doi = "10.1111/j.1553-2712.2000.tb01061.x",
language = "English (US)",
volume = "7",
pages = "211--221",
journal = "Academic Emergency Medicine",
issn = "1069-6563",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - The effects of graded doses of endothelin-1 on coronary perfusion pressure and vital organ blood flow during cardiac arrest

AU - Debehnke, Daniel

PY - 2000/3

Y1 - 2000/3

N2 - Background: Endothelin-1 (ET-1) is a potent vasoconstrictor and has been shown to improve coronary perfusion pressure (CPP) during arrest. The effects of ET-1 on organ blood flow during arrest have not been extensively studied. Objective: To investigate the effects of ET-1 on myocardial and cerebral blood flow during cardiac arrest. Methods: Sixty immature swine were anesthetized and instrumented. The animals were randomized to receive one of three doses of ET-1 (50, 150, or 300 μg) or placebo with/without standard- dose epinephrine (SDE) during cardiac arrest. After a 10-minute period of no- flow ventricular fibrillation (VF), cardiopulmonary resuscitation (CPR) was performed for 3 minutes, followed by drug administration. Placebo or SDE was given every 3 minutes. Myocardial and cerebral blood flow was measured using a fluorescent microsphere technique. Results: Prearrest and CPR variables were not different between groups. Beginning 4 minutes after giving 300 μg ET-1 with or without SDE, CPP was significantly increased compared with SDE alone. Total myocardial blood flow following ET-1 administration was no different than myocardial blood flow following SDE alone. Cerebral blood flow increased 3.5 minutes after administration of 300 μg ET-1 with SDE and reached significance 9.5 minutes after drug administration when compared with SDE alone [92.5 (48.8-117.9) vs 15.6 (7.7-23) mL/min/100 g]. Conclusions: Three hundred μg ET-1 with SDE increases CPP and improves cerebral blood flow but does not improve myocardial blood flow during cardiac arrest. The peripheral effects of ET-1 significantly improve CPP and cerebral blood flow, but myocardial blood flow is not increased due to coronary vasoconstriction.

AB - Background: Endothelin-1 (ET-1) is a potent vasoconstrictor and has been shown to improve coronary perfusion pressure (CPP) during arrest. The effects of ET-1 on organ blood flow during arrest have not been extensively studied. Objective: To investigate the effects of ET-1 on myocardial and cerebral blood flow during cardiac arrest. Methods: Sixty immature swine were anesthetized and instrumented. The animals were randomized to receive one of three doses of ET-1 (50, 150, or 300 μg) or placebo with/without standard- dose epinephrine (SDE) during cardiac arrest. After a 10-minute period of no- flow ventricular fibrillation (VF), cardiopulmonary resuscitation (CPR) was performed for 3 minutes, followed by drug administration. Placebo or SDE was given every 3 minutes. Myocardial and cerebral blood flow was measured using a fluorescent microsphere technique. Results: Prearrest and CPR variables were not different between groups. Beginning 4 minutes after giving 300 μg ET-1 with or without SDE, CPP was significantly increased compared with SDE alone. Total myocardial blood flow following ET-1 administration was no different than myocardial blood flow following SDE alone. Cerebral blood flow increased 3.5 minutes after administration of 300 μg ET-1 with SDE and reached significance 9.5 minutes after drug administration when compared with SDE alone [92.5 (48.8-117.9) vs 15.6 (7.7-23) mL/min/100 g]. Conclusions: Three hundred μg ET-1 with SDE increases CPP and improves cerebral blood flow but does not improve myocardial blood flow during cardiac arrest. The peripheral effects of ET-1 significantly improve CPP and cerebral blood flow, but myocardial blood flow is not increased due to coronary vasoconstriction.

KW - Blood flow

KW - Cardiac arrest

KW - Cardiopulmonary resuscitation

KW - Coronary perfusion pressure

KW - Endothelin

UR - http://www.scopus.com/inward/record.url?scp=0034090582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034090582&partnerID=8YFLogxK

U2 - 10.1111/j.1553-2712.2000.tb01061.x

DO - 10.1111/j.1553-2712.2000.tb01061.x

M3 - Article

C2 - 10730827

AN - SCOPUS:0034090582

VL - 7

SP - 211

EP - 221

JO - Academic Emergency Medicine

JF - Academic Emergency Medicine

SN - 1069-6563

IS - 3

ER -